Beth Moskow-Schnoll is Managing Partner of Ballard Spahr’s Delaware office and a member of the firm’s expanded board. She focuses her practice on white-collar defense, internal investigations, and complex civil litigation. A former federal prosecutor, Beth has extensive experience representing clients in regulatory enforcement and compliance matters, particularly allegations of health care fraud and bank and financial services fraud, including money laundering.
Beth counsels and defends pharmaceutical and medical device companies and diagnostic laboratories and their employees against government allegations of off-label marketing, kickbacks, and pricing violations and in False Claims Act (“whistleblower”) investigations. She also regularly advises on compliance issues relating to the sales and marketing of drugs, devices and diagnostic tests and conducts internal investigations for clients in a wide range of industries.
As lead counsel, Ms. Moskow-Schnoll has tried to verdict dozens of cases in federal district court. She also has successfully briefed and argued multiple cases before the Third Circuit Court of Appeals. Beth has convinced the government to decline prosecution of clients in matters involving allegations of health care fraud, financial fraud, defense procurement fraud and environmental crimes, and has conducted internal investigations for clients in the health care, banking, financial services, petroleum, defense and other industries. She was lead counsel for a defense contractor whose manufacturing facilities were raided by the government. Beth successfully negotiated a resolution that included no criminal prosecution and required no financial penalty or debarment.
Beth has advised and counseled clients on compliance programs and in responding to government investigative and enforcement actions. She has experience with export commodity classifications, jurisdiction requests, and preparation of license applications for submission to the Office of Foreign Asset Control, and has provided day-to-day counseling on licensing requirements and strategy.
In the civil arena, Beth represents major financial institutions, bringing actions against fraudulent debt relief companies and defending against consumer financial services lawsuits asserting a wide variety of claims.
Prior to joining Ballard Spahr, Beth worked for more than fifteen years with the U.S. Attorney’s Office for the District of Delaware, including five years as the office’s Criminal Healthcare Fraud Coordinator. In her role as Healthcare Fraud Coordinator, Beth prosecuted cases involving pharmaceutical and medical device fraud, drug diversions and fraudulent billing practices in the hospital, nursing home and ambulance industries. Among her notable achievements was the successful prosecution of a major pharmaceutical company that resulted in a criminal conviction and the largest monetary penalty in the history of the District of Delaware. She also led the office’s financial investigation working group and SAR review team, both of which were compromised of federal, state and local law enforcement. For her work as an AUSA, she received numerous honors and awards, including Special Commendations from the Food and Drug Administration, Health and Human Services Office of Inspector General, U.S. Secret Service, the U.S. Postal Inspection Service, the FBI and the IRS and was repeatedly named “Prosecutor of the Year” by the International Association of Financial Crimes Investigators.
Beth is a frequent writer and speaker on health care and financial fraud, including money laundering.
Beth received her law degree with honors from Stanford Law School and her undergraduate degree, summa cum laude, from the University of Pennsylvania.